Promoting Health through Vitamin D Therapeutics
Improving People's Lives by Treating and Preventing the Clinical Consequences of
Vitamin D Insufficiency and Secondary Hyperparathyroidism |
|
Recent News:
RAYALDEE® Launched in Germany by OPKO Health’s Licensee, VFMCRP
February 3, 2022
OPKO Health Announces Topline Results from Phase 2 Trial Evaluating RAYALDEE to Treat Symptomatic COVID-19 Outpatients
December 23, 2021
OPKO Health Completes Enrollment in Phase 2 Trial Evaluating RAYALDEE as a Treatment for Symptomatic COVID-19 Outpatients
August 30, 2021 |